C14-490
C14-490, an ionizable cationic lipid (pKa = 5.94), is used for the synthesis of lipid nanoparticles (LNPs) . C14-490 LNPs is used as the basis for subsequent study of in utero gene editing in HSCs. C14-490 LNPs are used to encapsulate SpCas9 mRNA and TTR sgRNA using optimized B5 formulation parameters and surface conjugation to CD45 antibody F (ab’) 2 fragments-Systematically optimized Targeted Editing Machinery LNPs (STEM LNPs) [1].
Product Specifications
CAS Number
2639634-82-3
UNSPSC
12352211
Target
Liposome
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Others
Smiles
OC(CCCCCCCCCCCC)CN(CC(CN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)OCC)CCN1CCN(CC(CN(CC(CCCCCCCCCCCC)O)CC(CCCCCCCCCCCC)O)OCC)CC1
Molecular Formula
C86H177N5O7
Molecular Weight
1393.35
References & Citations
[1]Rohan Palanki, et al. In utero delivery of targeted ionizable lipid nanoparticles facilitates in vivo gene editing of hematopoietic stem cells. Proc Natl Acad Sci U S A. 2024 Aug 6;121 (32) :e2400783121.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
QS0660Mo-01 48 Tests
Quick Step Mouse parvovirus (PV) elisa Kit (Quantitative)
Sign In for Pricing
View Details QS0660Mo-02 96 Tests
Quick Step Mouse parvovirus (PV) elisa Kit (Quantitative)
Sign In for Pricing
View Details 
E9279 96 Tests
Melatonin Receptor type 1A (MTNR1A) Porcine ELISA Kit
Sign In for Pricing
View Details